Steven G. Leeds
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Steven G. Leeds has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- Marc A. Ward
Department of Minimally Invasive Surgery, Baylor University Medical Center, Dallas, USA
13 shared publications Gerald O. Ogola
Department of Minimally Invasive Surgery, Baylor Scott & White Research Institute, Dallas, Texas
11 shared publicationsMarc A. Ward
Department of Minimally Invasive Surgery, Baylor University Medical Center, Dallas, USA
11 shared publicationsBola Aladegbami
Department of Minimally Invasive Surgery, Baylor University Medical Center, Dallas, USA
5 shared publicationsEstrellita Ontiveros
Center for Advanced Surgery, Baylor Scott and White Health, 3417 Gaston Avenue, Suite 1000 East, Dallas, TX, 75246, USA
5 shared publications- Ahmed Ebrahim
College of Medicine, Texas A&M Health Sciences CenterDallasTexas
4 shared publications
Latest Publications
- 9 September 2025
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 22 (1) , 40-46
Achieving optimal nutritional goals in management of patients with sleeve gastrectomy leaks with endoluminal vacuum therapy
- 9 September 2025
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 22 (1) , 40-46
Achieving optimal nutritional goals in management of patients with sleeve gastrectomy leaks with endoluminal vacuum therapy
- Open Access
- 28 August 2025
- Published by Springer Nature in Surgical Endoscopy
- Vol. 39 (10) , 6915-6923
Changes in peristalsis following per oral endoscopic myotomy in common esophageal motility disorders
Background: Per-oral endoscopic myotomy has been used for a diagnosis of achalasia and non-achalasia motility disorders. Little is known about the manometric function of the esophageal body and LES after POEM. This study focuses on examination of the changes before and after POEM in the treatment of all 3 achalasia types as well as esophagogastric junction outflow obstruction and jackhammer esophagus. Methods: A prospectively maintained IRB approved database was retrospectively reviewed to find patients who were diagnosed with any type of achalasia, esophagogastric junction outflow obstruction, and jackhammer esophagus, and underwent POEM. Patients were included if they had pre-operative and post-operative high-resolution manometry. Primary endpoints were to identify changes in peristalsis as well as other manometric findings. Results: There were 265 patients who met the inclusion criteria. Type 1 achalasia showed the most change in restoration of peristalsis after POEM at 45.5% of patients. Type 2 achalasia improved peristalsis, but not significant from 46.8 to 60.3%. Type 3 achalasia patients lost some peristalsis from 82.5% of patient having peristalsis to 64.5% of patients after POEM. The DCI in these patients returned to a normal range after the procedure. Similar findings were seen in jackhammer esophagus where the DCI returned to a normal range. Esophagogastric junction outflow obstruction showed the biggest changes after POEM losing some peristalsis, but the DCI and wave amplitude significantly decreased (4993.2 to 902.5, 111 to 43.8, respectively). Conclusion: Per-oral endoscopic myotomy is used for treatment of all types of achalasia and non-achalasia motility disorders. Peristalsis is regained in some patients with Type 1 and 2 achalasia, where some peristalsis is lost in Type 3 achalasia. Type 3 and jackhammer esophagus have normal DCI after the procedure, and esophagogastric junction outflow obstruction shows the poorest outcomes with some patients losing peristalsis, decrease in DCI and wave amplitude.
- 28 August 2025
- Published by Springer Nature in Surgical Endoscopy
- Vol. 39 (10) , 6915-6923
Open AccessChanges in peristalsis following per oral endoscopic myotomy in common esophageal motility disorders
Background: Per-oral endoscopic myotomy has been used for a diagnosis of achalasia and non-achalasia motility disorders. Little is known about the manometric function of the esophageal body and LES after POEM. This study focuses on examination of the changes before and after POEM in the treatment of all 3 achalasia types as well as esophagogastric junction outflow obstruction and jackhammer esophagus. Methods: A prospectively maintained IRB approved database was retrospectively reviewed to find patients who were diagnosed with any type of achalasia, esophagogastric junction outflow obstruction, and jackhammer esophagus, and underwent POEM. Patients were included if they had pre-operative and post-operative high-resolution manometry. Primary endpoints were to identify changes in peristalsis as well as other manometric findings. Results: There were 265 patients who met the inclusion criteria. Type 1 achalasia showed the most change in restoration of peristalsis after POEM at 45.5% of patients. Type 2 achalasia improved peristalsis, but not significant from 46.8 to 60.3%. Type 3 achalasia patients lost some peristalsis from 82.5% of patient having peristalsis to 64.5% of patients after POEM. The DCI in these patients returned to a normal range after the procedure. Similar findings were seen in jackhammer esophagus where the DCI returned to a normal range. Esophagogastric junction outflow obstruction showed the biggest changes after POEM losing some peristalsis, but the DCI and wave amplitude significantly decreased (4993.2 to 902.5, 111 to 43.8, respectively). Conclusion: Per-oral endoscopic myotomy is used for treatment of all types of achalasia and non-achalasia motility disorders. Peristalsis is regained in some patients with Type 1 and 2 achalasia, where some peristalsis is lost in Type 3 achalasia. Type 3 and jackhammer esophagus have normal DCI after the procedure, and esophagogastric junction outflow obstruction shows the poorest outcomes with some patients losing peristalsis, decrease in DCI and wave amplitude.
- 19 March 2025
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- Vol. 38 (3) , 362-367
History of surgery: Pioneers of esophageal pathology, anatomy, and surgical technique
Eponyms are prominently featured in medical terminology to describe pathologies, anatomical structures, or procedural techniques. Despite their common use, the historical names behind these terms are frequently overlooked. This article explores several well-known eponyms of the esophagus, highlighting the individuals whose accomplishments and contributions have helped shape the field. An extensive literature search via PubMed and online biographical accounts was carried out to examine the origins and historical context of these eponyms. Historical accounts were identified and selected that were relevant to each eponym. Each individual’s early life, professional life, and the origination of each eponym were identified and presented. It is important to recognize the individuals behind the terms and appreciate their lasting impact on the knowledge of the esophagus, diseases that affect it, and the management of those diseases.
- 19 March 2025
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- Vol. 38 (3) , 362-367
History of surgery: Pioneers of esophageal pathology, anatomy, and surgical technique
Eponyms are prominently featured in medical terminology to describe pathologies, anatomical structures, or procedural techniques. Despite their common use, the historical names behind these terms are frequently overlooked. This article explores several well-known eponyms of the esophagus, highlighting the individuals whose accomplishments and contributions have helped shape the field. An extensive literature search via PubMed and online biographical accounts was carried out to examine the origins and historical context of these eponyms. Historical accounts were identified and selected that were relevant to each eponym. Each individual’s early life, professional life, and the origination of each eponym were identified and presented. It is important to recognize the individuals behind the terms and appreciate their lasting impact on the knowledge of the esophagus, diseases that affect it, and the management of those diseases.
- 15 August 2024
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 28 (10) , 1682-1686
Magnetic sphincter augmentation vs subtotal gastrectomy with Roux-en-Y reconstruction for the treatment of postsleeve gastrectomy gastroesophageal reflux disease
- 15 August 2024
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 28 (10) , 1682-1686
Magnetic sphincter augmentation vs subtotal gastrectomy with Roux-en-Y reconstruction for the treatment of postsleeve gastrectomy gastroesophageal reflux disease
- 14 May 2024
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 28 (8) , 1325-1329
Predictability of magnetic sphincter augmentation device explantation: a nomogram-based scoring tool from an experienced quaternary center
- 14 May 2024
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 28 (8) , 1325-1329
Predictability of magnetic sphincter augmentation device explantation: a nomogram-based scoring tool from an experienced quaternary center
- 11 December 2023
- Published by Springer Nature in Surgical Endoscopy
- Vol. 38 (2) , 830-836
Coated poly-4-hydroxybutyrate (Phasix ST™) mesh is safe and effective for hiatal hernia repair: our institutional experience and review of the literature
Background Poly-4-hydroxybutyrate (P4HB) is a bioabsorbable mesh with a non-adhesive coating on one side that is being used to reinforce the hiatus during hiatal hernia repair; however, there is limited data regarding its use. The aim of this study was to investigate outcomes after hiatal hernia repair using this mesh at our institution and through a review of the literature. Methods An institutional review board-approved prospective database was retrospectively reviewed for all patients undergoing hiatal hernia repair from April 2018 to December 2022. A systematic review with meta-analysis was conducted to evaluate outcomes using P4HB coated mesh. Results In our institutional cohort, there were 230 patients (59 males; 171 females) with a mean follow-up of 20 ± 14.6 months. No mesh-related complications occurred. Hernia recurrence was diagnosed in 11 patients (4.8%) with a median time to recurrence of 16 months. In the systematic review, 4 studies with 221 patients (76 males; 145 females) were included. Median follow-up ranged from 12 to 27 months. Recurrence rate in these studies was reported from 0 to 8.8%, with a total of 12 recurrences identified. Like our institutional cohort, no mesh-related complications were reported. After our recurrences were combined with those from the systematic review, a total of 23 recurrences were included in the meta-analysis. Our meta-analysis revealed a low recurrence rate following hiatal hernia repair with P4HB coated mesh (incidence rate per 100 person-years, 2.82; 95% confidence interval, 1.60, 4.04). Conclusion P4HB coated mesh is safe and effective for hiatal hernia repairs.
- 11 December 2023
- Published by Springer Nature in Surgical Endoscopy
- Vol. 38 (2) , 830-836
Coated poly-4-hydroxybutyrate (Phasix ST™) mesh is safe and effective for hiatal hernia repair: our institutional experience and review of the literature
Background Poly-4-hydroxybutyrate (P4HB) is a bioabsorbable mesh with a non-adhesive coating on one side that is being used to reinforce the hiatus during hiatal hernia repair; however, there is limited data regarding its use. The aim of this study was to investigate outcomes after hiatal hernia repair using this mesh at our institution and through a review of the literature. Methods An institutional review board-approved prospective database was retrospectively reviewed for all patients undergoing hiatal hernia repair from April 2018 to December 2022. A systematic review with meta-analysis was conducted to evaluate outcomes using P4HB coated mesh. Results In our institutional cohort, there were 230 patients (59 males; 171 females) with a mean follow-up of 20 ± 14.6 months. No mesh-related complications occurred. Hernia recurrence was diagnosed in 11 patients (4.8%) with a median time to recurrence of 16 months. In the systematic review, 4 studies with 221 patients (76 males; 145 females) were included. Median follow-up ranged from 12 to 27 months. Recurrence rate in these studies was reported from 0 to 8.8%, with a total of 12 recurrences identified. Like our institutional cohort, no mesh-related complications were reported. After our recurrences were combined with those from the systematic review, a total of 23 recurrences were included in the meta-analysis. Our meta-analysis revealed a low recurrence rate following hiatal hernia repair with P4HB coated mesh (incidence rate per 100 person-years, 2.82; 95% confidence interval, 1.60, 4.04). Conclusion P4HB coated mesh is safe and effective for hiatal hernia repairs.
- 12 June 2023
- Published by Springer Nature in Surgical Endoscopy
- Vol. 37 (8) , 6538-6547
Comparison of long-term quality of life outcomes between endoscopic vacuum therapy and other treatments for upper gastrointestinal leaks
Background While endoscopic vacuum assisted closure (EVAC) therapy is a validated treatment for gastrointestinal leaks, its impact on long-term quality of life (QoL) is uncertain. The purpose of this study was to evaluate the impact of successful EVAC management on long-term QoL outcomes. Methods An institutional review board approved prospectively maintained database was retrospectively reviewed to identify patients undergoing treatment for gastrointestinal leaks between June 2012 and July 2022. The Short-Form 36 (SF-36) survey was used to assess QoL. Patients were contacted by telephone and sent the survey electronically. QoL outcomes between patients who underwent successful EVAC therapy and those who required conventional treatment (CT) were analyzed and compared. Results A total of 44 patients (17 EVAC; 27 CT) completed the survey and were included in our analysis. All included patients had foregut leaks with sleeve gastrectomy being the most common sentinel operation (n = 20). The mean time from the sentinel operation was 3.8 years and 4.8 years for the EVAC and CT groups, respectively. When evaluating long-term QoL, the EVAC group scored higher in all QoL domains when compared to the CT group with physical functioning (87.3 vs 69.3, p = 0.04), role limitations due to physical health (84.1 vs 45.7, p = 0.02), energy/fatigue (60.0 vs 40.9, p = 0.04), and social functioning (86.2 vs 64.1, p = 0.04) reaching statistical significance. Overall, patients who achieved organ preservation via successful EVAC therapy scored higher in all domains with role limitations due to physical health (p = 0.04) being statistically significant. In a multivariable regression analysis, increased age and a history of prior abdominal surgery at the time of the sentinel operation were patient characteristics that negatively impacted QoL outcomes. Conclusion Patients with gastrointestinal leaks successfully managed by EVAC therapy have better long-term QoL outcomes when compared to patients undergoing other treatments. Graphical abstract
- 12 June 2023
- Published by Springer Nature in Surgical Endoscopy
- Vol. 37 (8) , 6538-6547
Comparison of long-term quality of life outcomes between endoscopic vacuum therapy and other treatments for upper gastrointestinal leaks
Background While endoscopic vacuum assisted closure (EVAC) therapy is a validated treatment for gastrointestinal leaks, its impact on long-term quality of life (QoL) is uncertain. The purpose of this study was to evaluate the impact of successful EVAC management on long-term QoL outcomes. Methods An institutional review board approved prospectively maintained database was retrospectively reviewed to identify patients undergoing treatment for gastrointestinal leaks between June 2012 and July 2022. The Short-Form 36 (SF-36) survey was used to assess QoL. Patients were contacted by telephone and sent the survey electronically. QoL outcomes between patients who underwent successful EVAC therapy and those who required conventional treatment (CT) were analyzed and compared. Results A total of 44 patients (17 EVAC; 27 CT) completed the survey and were included in our analysis. All included patients had foregut leaks with sleeve gastrectomy being the most common sentinel operation (n = 20). The mean time from the sentinel operation was 3.8 years and 4.8 years for the EVAC and CT groups, respectively. When evaluating long-term QoL, the EVAC group scored higher in all QoL domains when compared to the CT group with physical functioning (87.3 vs 69.3, p = 0.04), role limitations due to physical health (84.1 vs 45.7, p = 0.02), energy/fatigue (60.0 vs 40.9, p = 0.04), and social functioning (86.2 vs 64.1, p = 0.04) reaching statistical significance. Overall, patients who achieved organ preservation via successful EVAC therapy scored higher in all domains with role limitations due to physical health (p = 0.04) being statistically significant. In a multivariable regression analysis, increased age and a history of prior abdominal surgery at the time of the sentinel operation were patient characteristics that negatively impacted QoL outcomes. Conclusion Patients with gastrointestinal leaks successfully managed by EVAC therapy have better long-term QoL outcomes when compared to patients undergoing other treatments. Graphical abstract
- 19 January 2023
- Published by Springer Nature in Surgical Endoscopy
- Vol. 37 (3) , 2347-2353
Probability of additional intervention and long-term follow-up of esophagomyotomy
Introduction Two common surgical procedures used to treat esophageal motility disorders are laparoscopic Heller myotomy (LHM) with partial fundoplication and per-oral endoscopic myotomy (POEM). The difference in frequency of follow-up interventions following these procedures is unknown. This study was designed to report differences in post-surgical interventions as one of the major long-term follow-up expectations. Methods An IRB approved registry was used to identify all patients undergoing surgery with LHM or POEM. Following surgery, patients requiring additional interventions with esophageal non-pneumatic dilation, botox injection, or repeat myotomy, as well as persistent proton pump inhibitor (PPI) use were recorded. Multivariable logistic regression analysis was performed to estimate risk factors associated with return for additional post-operative intervention. Results A total of 203 patients were identified, 139 met inclusion criteria (33 LHM and 106 POEM). There was a higher rate of non-pneumatic EGD dilation (33% vs 15%, p = 0.04), repeat myotomy (18% vs 2%, p < 0.01), and higher rate of overall post-operative intervention in LHM than POEM. With POEM, there was a higher rate of post-operative PPI use (63 vs 29%, p < 0.01). There was no difference in time to post-operative intervention for either group, but if intervention were to occur the median time was within the first year. Patients with a change in pre- to post-operative Eckardt score of 4 or greater decreased their chance of having a post-operative intervention. Conclusion Our results for both LHM and POEM emphasize the importance of long-term follow-up in patients with an esophageal motility disorder. We have found that patients undergoing LHM are more likely to have a post-operative intervention as well as a higher rate of repeat myotomy than POEM. With both interventions, a greater change in Eckardt score decreased the likelihood of reintervention.
- 19 January 2023
- Published by Springer Nature in Surgical Endoscopy
- Vol. 37 (3) , 2347-2353
Probability of additional intervention and long-term follow-up of esophagomyotomy
Introduction Two common surgical procedures used to treat esophageal motility disorders are laparoscopic Heller myotomy (LHM) with partial fundoplication and per-oral endoscopic myotomy (POEM). The difference in frequency of follow-up interventions following these procedures is unknown. This study was designed to report differences in post-surgical interventions as one of the major long-term follow-up expectations. Methods An IRB approved registry was used to identify all patients undergoing surgery with LHM or POEM. Following surgery, patients requiring additional interventions with esophageal non-pneumatic dilation, botox injection, or repeat myotomy, as well as persistent proton pump inhibitor (PPI) use were recorded. Multivariable logistic regression analysis was performed to estimate risk factors associated with return for additional post-operative intervention. Results A total of 203 patients were identified, 139 met inclusion criteria (33 LHM and 106 POEM). There was a higher rate of non-pneumatic EGD dilation (33% vs 15%, p = 0.04), repeat myotomy (18% vs 2%, p < 0.01), and higher rate of overall post-operative intervention in LHM than POEM. With POEM, there was a higher rate of post-operative PPI use (63 vs 29%, p < 0.01). There was no difference in time to post-operative intervention for either group, but if intervention were to occur the median time was within the first year. Patients with a change in pre- to post-operative Eckardt score of 4 or greater decreased their chance of having a post-operative intervention. Conclusion Our results for both LHM and POEM emphasize the importance of long-term follow-up in patients with an esophageal motility disorder. We have found that patients undergoing LHM are more likely to have a post-operative intervention as well as a higher rate of repeat myotomy than POEM. With both interventions, a greater change in Eckardt score decreased the likelihood of reintervention.
- 8 April 2022
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 235 (1) , 26-33
Predictability of Endoscopic Success for Foregut and Bariatric Leak in an Experienced Quaternary Center
Export BACKGROUND: Leaks of the esophagus and stomach are difficult to manage and associated with significant morbidity and mortality. Endoscopic therapy can manage these leaks without surgical intervention. Our goal is to create a scoring tool to aid in predicting the success of endoscopic therapy in these patients. STUDY DESIGN: An IRB-approved prospectively maintained database was retrospectively reviewed for all patients treated for gastrointestinal leaks from July 2013 to January 2021, including patients treated for esophageal and stomach leaks. Endpoints include success of leak closure for patients treated solely by endoscopic therapy (ET) compared with surgical therapy as failed endoscopic therapy (FET). A multivariable logistic regression model was fitted to identify independent risk factors for predicting success of endoscopic therapy, and a scoring calculator was developed. RESULTS: There were 80 patients (60 females) with a mean age of 50 years. The ET group included 59 patients (74%), whereas the FET group included 21 patients (26%). Patient demographics, comorbidities, surgical history, and timing of leak diagnosis were used. Multivariable analysis resulted in 4 variables associated with higher probability of successful endoscopic leak management without need for additional surgery. These included increased age, lower BMI, lack of previous bariatric surgery, and quicker identification of the leak. Consequently, a scoring nomogram was developed with values from 0 to 22. CONCLUSION: Our data show the development of a scoring calculator capable of quantifying the likelihood of success treating foregut and bariatric leaks with endoscopic therapies. This can be used clinically to guide treatment decisions.
- 8 April 2022
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 235 (1) , 26-33
Predictability of Endoscopic Success for Foregut and Bariatric Leak in an Experienced Quaternary Center
Export BACKGROUND: Leaks of the esophagus and stomach are difficult to manage and associated with significant morbidity and mortality. Endoscopic therapy can manage these leaks without surgical intervention. Our goal is to create a scoring tool to aid in predicting the success of endoscopic therapy in these patients. STUDY DESIGN: An IRB-approved prospectively maintained database was retrospectively reviewed for all patients treated for gastrointestinal leaks from July 2013 to January 2021, including patients treated for esophageal and stomach leaks. Endpoints include success of leak closure for patients treated solely by endoscopic therapy (ET) compared with surgical therapy as failed endoscopic therapy (FET). A multivariable logistic regression model was fitted to identify independent risk factors for predicting success of endoscopic therapy, and a scoring calculator was developed. RESULTS: There were 80 patients (60 females) with a mean age of 50 years. The ET group included 59 patients (74%), whereas the FET group included 21 patients (26%). Patient demographics, comorbidities, surgical history, and timing of leak diagnosis were used. Multivariable analysis resulted in 4 variables associated with higher probability of successful endoscopic leak management without need for additional surgery. These included increased age, lower BMI, lack of previous bariatric surgery, and quicker identification of the leak. Consequently, a scoring nomogram was developed with values from 0 to 22. CONCLUSION: Our data show the development of a scoring calculator capable of quantifying the likelihood of success treating foregut and bariatric leaks with endoscopic therapies. This can be used clinically to guide treatment decisions.
- 26 February 2022
- Published by Springer Nature in Obesity Surgery
- Vol. 32 (5) , 1421-1427
Nutritional Support and Duration of Drainage Recommendations for Endoscopic Internal Drainage: Review of the Literature and Initial Experience
Introduction Anastomotic leaks following foregut surgery pose a difficult scenario for surgeons. While definitive surgical options are more invasive and may result in diversion requiring subsequent surgeries, endoscopic management of these leaks has been shown to work as an alternative platform for management. An evolving option is endoscopic internal drainage. We have reviewed our experience using endoscopic internal drainage and report our outcomes. Materials and Methods An institution review board approved prospectively gathered database was used to identify all patients undergoing endoscopic internal drainage following esophageal and gastric leaks. Patient demographics, sentinel operation causing the leak, and outcomes of therapy were collected. The rate of healing and complications with the drainage catheter in place were the primary endpoints. Results Sixteen patients were identified (5 male, 11 female) that underwent endoscopic internal drainage with a mean age of 48 and mean BMI of 30.8. Overall success rate was 69% (11/16), where 4 patients required a definitive surgery, and one healed with endoluminal vacuum therapy. Of the 4 failures, 1 patient required esophagojejunostomy, 2 patients required a fistulojejunostomy, and one required a partial gastrectomy. A total of 12 patients (75%) had a prior endoscopic procedure that was unsuccessful. The mean duration of drainage catheter in place was 48 days. While the catheter was in place, 4 patients were allowed minimal PO intake in conjunction with total parenteral nutrition or tube feeds. The rest of the patients were strict NPO with other means of nutrition. There were no complications with the drainage catheters and no deaths. Conclusion Leaks following esophagogastric surgery are difficult to manage; however, endoscopic internal drainage has been shown to be effective. Duration of the technique should be around 6 to 8 weeks with nutritional support guided by the comfort of the managing clinician. Graphical abstract
- 26 February 2022
- Published by Springer Nature in Obesity Surgery
- Vol. 32 (5) , 1421-1427
Nutritional Support and Duration of Drainage Recommendations for Endoscopic Internal Drainage: Review of the Literature and Initial Experience
Introduction Anastomotic leaks following foregut surgery pose a difficult scenario for surgeons. While definitive surgical options are more invasive and may result in diversion requiring subsequent surgeries, endoscopic management of these leaks has been shown to work as an alternative platform for management. An evolving option is endoscopic internal drainage. We have reviewed our experience using endoscopic internal drainage and report our outcomes. Materials and Methods An institution review board approved prospectively gathered database was used to identify all patients undergoing endoscopic internal drainage following esophageal and gastric leaks. Patient demographics, sentinel operation causing the leak, and outcomes of therapy were collected. The rate of healing and complications with the drainage catheter in place were the primary endpoints. Results Sixteen patients were identified (5 male, 11 female) that underwent endoscopic internal drainage with a mean age of 48 and mean BMI of 30.8. Overall success rate was 69% (11/16), where 4 patients required a definitive surgery, and one healed with endoluminal vacuum therapy. Of the 4 failures, 1 patient required esophagojejunostomy, 2 patients required a fistulojejunostomy, and one required a partial gastrectomy. A total of 12 patients (75%) had a prior endoscopic procedure that was unsuccessful. The mean duration of drainage catheter in place was 48 days. While the catheter was in place, 4 patients were allowed minimal PO intake in conjunction with total parenteral nutrition or tube feeds. The rest of the patients were strict NPO with other means of nutrition. There were no complications with the drainage catheters and no deaths. Conclusion Leaks following esophagogastric surgery are difficult to manage; however, endoscopic internal drainage has been shown to be effective. Duration of the technique should be around 6 to 8 weeks with nutritional support guided by the comfort of the managing clinician. Graphical abstract